BioCryst Pharmaceuticals | BCRX - Aktiva





Aktiva Perubahan Tanggal
Alnylam Pharmaceuticals USD 5.56B 429.22M 2026-06
BioCryst Pharmaceuticals USD 557.85M 92.8M 2026-06
Chugai Pharma JPY 2.45T 184.81B 2026-06
Daiichi Sankyo JPY 4.11T 109.16B 2026-06
DBV Technologies USD 223.2M 43.2M 2026-06
Enanta Pharmaceuticals USD 329.5M 48.77M 2025-12
Gilead Sciences USD 49.36B 6.92B 2026-06
GlaxoSmithKline GBP 61.74B 1.13B 2026-06
Glaxosmithkline GBP 62.87B 19.47B 2026-03
Incyte USD 7.87B 533.53M 2026-06
Ionis Pharmaceuticals USD 2.99B 455.5M 2026-06
Karyopharm Therapeutics USD 131.42M 23M 2026-03
Neurocrine Biosciences USD 5.36B 452.9M 2026-06
Novavax USD 955.58M 87.59M 2026-06
PTC Therapeutics USD 3.25B 381.37M 2026-06
Regeneron Pharmaceuticals USD 41.73B 861.8M 2026-06
Roche Holding CHF 98.2B 2.5B 2026-06
Sarepta Therapeutics USD 3.19B 9.58M 2026-06
Ultragenyx Pharmaceutical USD 1.26B 32M 2026-06
Vertex Pharmaceuticals USD 27.42B 938.9M 2026-06